Glimpse Group ends $9.48M ATM offering

The Glimpse Group, Inc. is terminating the use of its prior prospectus supplement for an At-the-Market sales program that had authorized an $9,478,200 aggregate offering price of common stock under a Sales Agreement with WestPark Capital.

Rhea-AI Filing Summary

The Glimpse Group, Inc. is terminating the use of its prior prospectus supplement for an At-the-Market sales program that had authorized an $9,478,200 aggregate offering price of common stock under a Sales Agreement with WestPark Capital.

The company is not terminating the Sales Agreement itself, states it sold no shares under that Prior Prospectus through the Sales Agent, and identifies itself as an emerging growth company. The last reported sale price quoted is $0.81 per share on May 22, 2026.

Insights

Capital Markets Counsel

Terminates ATM offering authority but leaves agreement in place.

The supplement notifies termination of the continuous offering under the prior prospectus supplement that permitted up to $9,478,200 of common stock sales under an At-the-Market Sales Agreement with WestPark Capital. It also states the issuer sold no shares under that arrangement through the Sales Agent.

The filing preserves the Sales Agreement while ending the prospectus-based offering; subsequent funding options and any renewed offering would require further prospectus amendments or supplements. Cash-flow treatment and future use of proceeds are not described in this excerpt.

Key Figures

Base shelf capacity: $100,000,000 ATM aggregate offering price: $9,478,200 Last reported sale price: $0.81 per share

3 metrics

Base shelf capacity $100,000,000 Base Prospectus dated November 26, 2025

ATM aggregate offering price $9,478,200 At-the-Market Sales Agreement prospectus supplement

Last reported sale price $0.81 per share Nasdaq Capital Market on May 22, 2026

Key Terms

At-the-Market Sales Agreement, Prospectus Supplement, emerging growth company

3 terms

At-the-Market Sales Agreement financial

"offering of shares of our common stock... pursuant to an At-the-Market Sales Agreement"

An at-the-market sales agreement lets a company raise cash by selling newly issued shares directly into the open market at whatever price buyers are paying that day, using a broker to place the trades over time. Investors should watch these deals because they can dilute existing ownership and put downward pressure on the stock price while giving the company flexible, on-demand funding—like a store gradually listing extra items on an online marketplace at current prices.

Prospectus Supplement regulatory

"This Prospectus Supplement should be read in conjunction with the Prior Prospectus"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

emerging growth company regulatory

"We are an "emerging growth company" as defined under federal securities laws"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Offering Details

ATM · $9,478,200

Offering

Offering Type ATM

Securities Offered common stock

Offering Amount $9,478,200

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Glimpse Group (GGRP) change in this prospectus supplement?

It terminated the use of the prior prospectus supplement that authorized an ATM program. The supplement cancels the continuous offering authority tied to the Sales Agreement while not terminating the Sales Agreement itself.

How large was the At-the-Market offering authority being ended?

The prior prospectus authorized an aggregate offering price of $9,478,200 of common stock for sales under the At-the-Market Sales Agreement with WestPark Capital, as stated in the supplement.

Did Glimpse Group sell any shares under the prior ATM prospectus?

No. The supplement explicitly states the company has not sold any shares of its common stock under the Prior Prospectus through the Sales Agent, per the filing language.

What is Glimpse Group's quoted share price noted in the supplement?

The supplement reports the last reported sale price as $0.81 per share on May 22, 2026, quoted from the Nasdaq Capital Market where the common stock trades under the symbol GGRP.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 06:03 AM EDT Learn about SEC filing dates

Supplement No. 1 to Prospectus Supplement dated November 26, 2025, as amended on January 2, 2026 (To Prospectus Supplement dated November 26, 2025 and Prospectus Dated November 26, 2025) Filed pursuant to Rule 424(b)(3) Registration No. 333-291727

THE GLIMPSE GROUP, INC.

This supplement no. 1 to the prospectus supplement, or this Prospectus Supplement, amends and supplements the information in (i) the base prospectus, dated November 26, 2025, or the Base Prospectus, filed with the Securities and Exchange Commission pursuant to our registration statement on Form S-3 (File No. 333-291727), relating to the offer and sale of up to $100,000,000 of securities and (ii) the at-the-market sales agreement prospectus supplement to the Base Prospectus, dated November 26, 2025, as amended by amendment no. 1 to the at-the-market sales agreement prospectus supplement, dated January 2, 2026 (together with the Base Prospectus, the “Prior Prospectus”), relating to an offering of shares of our common stock, par value $0.001 per share, having an aggregate offering price of up to $9,478,200 from time to time pursuant to an At-the-Market Sales Agreement, or the Sales Agreement, with WestPark Capital, Inc., or the Sales Agent. This Prospectus Supplement should be read in conjunction with the Prior Prospectus, and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prior Prospectus. This Prospectus Supplement is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectus and any future amendments or supplements thereto.

By this Prospectus Supplement, we are notifying that we have terminated the use of the Prior Prospectus for the offer and sale of shares of our common stock under the Sales Agreement. We are not terminating the Sales Agreement with the Sale Agent. We have not sold any shares of our common stock under the Prior Prospectus through the Sales Agent.

We are an “emerging growth company” as defined under federal securities laws, and, as such, have elected to comply with certain reduced public company reporting requirements for the Prior Prospectus and this Prospectus Supplement, and may elect to comply with reduced public company reporting requirements in future filings.

Our common stock is listed on the Nasdaq Capital Market under the symbol “GGRP.” The last reported sale price of our common stock on the Nasdaq Capital Market on May 22, 2026 was $0.81 per share.

The purpose of this Prospectus Supplement is to terminate our continuous offering under the Prior Prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus Supplement or the Prior Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this Prospectus Supplement is May 26, 2026